Dental Soft-Tissue Regeneration Market

The report "Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030", is projected to reach USD 0.53 billion in 2030 from USD 0.38 billion in 2025, at a CAGR of 6.8% between 2025 and 2030.

Browse 300 market data Tables and 50 Figures spread through 330 Pages and in-depth TOC on "Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/dental-soft-tissue-regeneration-market-198310783.html

The dental soft-tissue regeneration market is primarily driven by several factors, including the increasing prevalence of dental diseases, a growing elderly population, and heightened awareness of oral health. Additionally, advancements in technology, such as laser therapy, advanced biomaterials, and 3D bioprinting, along with the availability of dental insurance in many regions, have significantly improved access to dental care, further promoting growth in this market. Government efforts to enhance oral health and the rising number of specialized dental clinics and providers are also contributing positively to market expansion. However, high operational costs and stringent regulations pose challenges to market growth.

Collagen-based membranes are expected to account for the largest share of the dental soft-tissue regeneration market, by product type, during the forecast period.

The collagen-based membrane segment holds the largest share of the dental soft-tissue regeneration market. These membranes, derived from natural sources such as bovine or porcine collagen, closely resemble the extracellular matrix of human tissues. This resemblance promotes cell adhesion, proliferation, and differentiation, making them biocompatible and versatile. Collagen-based membranes are commonly used in periodontal and implant surgeries due to their availability in various sizes and thicknesses. This wide range of options contributes to their increased adoption and drives market growth.

The implantology segment is expected to account for the largest share of the dental soft-tissue regeneration market, by application, during the forecast period.

The implantology segment holds the largest share of the dental soft-tissue regeneration market. This is primarily due to the increasing prevalence of the geriatric population, which experiences a high rate of edentulism. Additionally, there is a growing demand from patients for minimally invasive surgeries.

Furthermore, this segment's significant market share can be attributed to the rise in periodontal diseases and the increasing demand for aesthetic dental restorations. These procedures often require advanced biomaterials, such as collagen membranes and soft-tissue grafts, which promote natural healing and ensure long-term implant stability.

DSOs & independent clinics are expected to account for the largest share of the dental soft-tissue regeneration market, by end user, during the forecast period.

The DSOs & independent clinics segment holds the largest share of the dental soft-tissue regeneration market, driven by a consistent and strong demand for dental restoration and regeneration products. Additionally, the trend of dental tourism has been advantageous for DSOs & independent clinics, attracting patients who seek high-quality dental treatments at competitive prices. This influx of patients has contributed to the growth of clinic-based services in the dental soft-tissue regeneration market.

In 2024, North America accounted for the largest share of the dental soft-tissue regeneration market.

The dental soft-tissue regeneration market is divided into five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa, including the GCC countries.

North America leads the dental soft-tissue regeneration market, primarily due to its advanced healthcare systems, high healthcare expenditures, and the presence of key industry players. This region encompasses the US, which boasts a comprehensive network of hospitals and research institutions and has an aging population that requires periodontal treatments due to a high rate of edentulism. Furthermore, enhanced healthcare accessibility through government initiatives, along with the adoption of advanced technologies such as laser therapy and non-surgical treatments, has been crucial to the growth of this market in the region.

Key Market Players

The key players in the global dental soft-tissue regeneration market include Geistlich Pharma AG (Switzerland), DENTSPLY Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent AG (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czech Republic), KeystoneDentalGroup (US), Neoss AG (Switzerland), BEGO GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US). These companies play a significant role in advancing dental soft-tissue regeneration techniques and products globally.

Don’t miss out on business opportunities in Dental Soft-tissue Regeneration Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/